Chemistry and Chemical Biology fellowships awarded

Each year, the Department of Chemistry and Chemical Biology receives a number of corporate fellowships instrumental in the training of graduate students in organic chemistry. The 2000-01 research fellowships are sponsored by Eli Lilly Research Laboratories, Hoffmann-La Roche Inc., and Bristol-Myers Squibb Pharmaceutical Research. Ten graduate students have been awarded the fellowships this year.

Eli Lilly Pre-doctoral Fellowships

Eli Lilly is a global research-based pharmaceutical company that has marketed several drugs for the treatment of cancer, schizophrenia, osteoporosis, diabetes, depression, and cardiovascular complications. Eli Lilly has recently increased its annual support to $150,000, and has given the department of chemistry graduate fellowship support since 1991. The 2000-01 Eli Lilly Pre-doctoral Fellowship recipients are David Barnes-Seeman, Jeffrey Johannes, Joseph Ready, Ryan Spoering, and Michael Storek.

Roche Fellowships

Hoffmann-La Roche is involved in the therapeutic areas of oncology; metabolic diseases, including obesity and diabetes; virology, including HIV; influenza and hepatitis C; as well as inflammation/autoimmune, vascular, and genitourinary diseases. In 1997, the company established a five-year fellowship with the chemistry department, which provides $100,000 annually for organic synthesis research of five graduate students.

The Roche Fellows for 2000-01 are Anirban Banerjee, Carl Morales, Mohammad Movassaghi, Gretchen Peterson, and Scott Sternson.

Bristol-Myers Squibb Fellowships in Synthetic Organic Chemistry

The Bristol-Myers Squibb Pharmaceutical Research Institute’s research portfolio spans therapeutic areas in oncology, cardiovascular disease, metabolic disease, infectious disease, immunology/inflammation, neuroscience, pain management, dermatological disease, and pulmonary disease. In 1998, the company awarded the department a three-year fellowship of $38,000 annually for research in organic synthesis and an annual symposium. Krista Beaver Goodman is the third Bristol-Myers Squibb Graduate Fellow.